🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
To evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus...
Status
Unknown
Location
Seoul National University Hosipital
Start Date
2021-03-16
Trial ID
NCT04867720
Treatments Being Tested
Idiopathic inflammatory myopathies (IIM) are a group of autoimmune conditio...
Status
Recruiting
Location
Singapore General Hospital
Start Date
2024-12-26
Trial ID
NCT07775235
Treatments Being Tested
Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2006-01
Trial ID
NCT00260208
Treatments Being Tested
The purpose of this study is to evaluate the influence of sirolimus on outc...
Status
Unknown
Location
Liver Cancer Institute and Zhongshan Hospital, Fudan University
Start Date
2007-08
Trial ID
NCT00554125
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-01-29
Trial ID
NCT00053989
Treatments Being Tested
The purpose of this study is to learn if changing from Tacrolimus to Everol...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2018-02-01
Trial ID
NCT03413722
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine and melpha...
Status
Terminated
Location
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Start Date
2005-07
Trial ID
NCT00121186